Koningshooikt, Belgium

Tom François L Van Dooren


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Tom François L Van Dooren: Innovator in Neurodegenerative Disorder Treatments**

Introduction

Tom François L Van Dooren is a notable inventor based in Koningshooikt, Belgium. He has contributed to the field of medical science with his innovative work focused on the treatment and prevention of epilepsy and neurodegenerative disorders. With one patent to his name, his research has the potential to impact many lives.

Latest Patents

Van Dooren's significant patent is titled "Inhibitors of PDE6Delta for use in the prevention and/or treatment of epilepsy and/or neurodegenerative disorders." This invention provides novel compounds and methods aimed at preventing and treating these debilitating conditions. The patent emphasizes the use of inhibitors of PDE6δ, specifically designed to target neurodegenerative disorders and epilepsy.

Career Highlights

Throughout his career, Tom François L Van Dooren has worked with prominent organizations, including Remynd NV, where he applied his expertise in the medical research domain. Additionally, he has collaborated with the Katholieke Universiteit Leuven, a leading research institution in Belgium known for its contributions to various fields, including health sciences.

Collaborations

Van Dooren has had the opportunity to collaborate with distinguished colleagues, including Johan Gerard Griffioen and Katrien Princen. These collaborations have likely enriched his research and fostered an environment conducive to innovation.

Conclusion

Tom François L Van Dooren stands out as an inventor whose work holds promise for advancing treatments in neuroscience. With his dedication to research and innovation, he continues to pave the way for improvements in how epilepsy and neurodegenerative disorders are addressed, ultimately striving to enhance patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…